Annual report pursuant to Section 13 and 15(d)

Common Stock and Equity Payable (Details)

v3.22.1
Common Stock and Equity Payable (Details)
1 Months Ended 12 Months Ended
Sep. 17, 2020
$ / shares
shares
Mar. 02, 2020
$ / shares
shares
Dec. 31, 2020
USD ($)
item
$ / shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Shares issued | shares 15,000 234,500   0 1,113,767
Strike price per share | $ / shares $ 0.48 $ 1.00      
Ratio of converted warrant units | item     1    
Sale of common stock | shares         2,666,459
Proceeds from sale of common stock         $ 3,333,074
Loss on conversion         (668,260)
Equity payable     $ 100,862   100,862
Warrant Issuance [Member]          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Exercise price | $ / shares     $ 1.25    
New Warrant [Member]          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Exercise price | $ / shares     $ 2.00    
Restricted Stock Units RSU [Member]          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Stock-based compensation expense       $ 447,506 260,003
Restricted Stock Units RSU [Member] | Board of Directors [Member]          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Stock-based compensation expense       260,005 260,003
Restricted Stock Units RSU [Member] | Employees [Member]          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Stock-based compensation expense       $ 187,501  
Principal [Member]          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Face amount         1,200,000
Accrued Interest [Member]          
Fair Value Measurement Inputs and Valuation Techniques [Line Items]          
Face amount         $ 192,208